1. Home
  2. CODX

CODX

Co-Diagnostics Inc.

Logo Co-Diagnostics Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 37.8M IPO Year: 2017
Target Price: $2.50 AVG Volume (30 days): 60.2K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.20 EPS Growth: N/A
52 Week Low/High: $0.97 - $1.89 Next Earning Date: 05-09-2024
Revenue: $6,812,038 Revenue Growth: -80.09%
Revenue Growth (this year): -12.77% Revenue Growth (next year): N/A

Share on Social Networks: